{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:27:18Z","timestamp":1794050838559,"version":"4.8.0"},"reference-count":30,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T00:00:00Z","timestamp":1089936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> To assess the trends in the number, mortality and the nature of forensic cases involving toxicological detection of buprenorphine or methadone among toxicological investigations performed in Paris from June 1997 to June 2002.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> Retrospective, 5\u2003year study with review of premortem data, autopsy, police reports, hospital data, and post\u2010mortem toxicological analyses.<\/jats:p><jats:p><jats:bold>Setting and participants\u2003<\/jats:bold> 34 forensic cases of buprenorphine and 35 forensic cases of methadone detection among 1600 toxicological investigations performed at the Laboratory of Toxicology in the Medical Examiner's Office in Paris.<\/jats:p><jats:p><jats:bold>Measurements and results\u2002<\/jats:bold> Therapeutic, toxic or lethal drug concentrations were defined based upon the results of blood analyses and the published literature. Drug concentrations were cross\u2010referenced with other available ante\u2010 and post\u2010mortem data. Subsequently, we classified a \u2018clear responsibility\u2019, \u2018possible responsibility\u2019 or \u2018not causative\u2019 role for buprenorphine or methadone in the death process, or \u2018no explanation of death\u2019. Buprenorphine and methadone can be regarded as being directly implicated in, respectively, four of 34 death cases (12%) and three of 35 death cases (9%), and their participation in the lethal process is strongly plausible in eight (buprenorphine) and 11 (methadone) additional deaths.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> Analysis of causes of death reveals the difficulties in determining the role of substitution drugs in the death process, as many other factors may be involved, including circumstances surrounding death, past history, differential selection of subjects<\/jats:p><jats:p>into either substitution modality and concomitant intake of other drugs (especially benzodiazepines and neuroleptics). The potential for synergistic or additive actions by other isolated molecules\u2014particularly opioids, benzodiazepines, other psychotropes and alcohol\u2014must be also considered.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2004.00790.x","type":"journal-article","created":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T14:51:29Z","timestamp":1089989489000},"page":"978-988","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["A critical review of the causes of death among post\u2010mortem toxicological investigations: analysis of 34 buprenorphine\u2010associated and 35 methadone\u2010associated deaths"],"prefix":"10.1111","volume":"99","author":[{"given":"S.","family":"Pirnay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W.","family":"Borron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Giudicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ricordel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,16]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011023431802"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93913859.x"},{"key":"e_1_2_8_4_2","first-page":"557","article-title":"Intoxications aigu\u00ebs par traitement substitutif \u00e0 base de bupr\u00e9norphine haut dosage. 29 observations cliniques\u201420 cas mortels. [Acute poisoning during substitution therapy based on high\u2010dosage buprenorphine. 29 clinical cases\u201420 fatal cases]","volume":"27","author":"Tracqui A.","year":"1998","journal-title":"Presse Medicale"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.6.430"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90036-P"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(01)00454-6"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1520\/JFS14667J"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000433-199309000-00012"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1995.9079598.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.3.447-b"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.4.277"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18032"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2002.tb00185.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2002.tb00188.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(02)00190-5"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659709001158"},{"key":"e_1_2_8_18_2","volume-title":"Toxicologie et Pharmacologie M\u00e9dico\u2010L\u00e9gales [Forensic Toxicology and Pharmacology].","author":"Kintz P.","year":"1998"},{"key":"e_1_2_8_19_2","volume-title":"Substitution aux Opiac\u00e9s en France, Synth\u00e8se des Informations Disponibles de 1996 \u00e0 2001 [Substitution to Opiates in France, Summary of Available Data between 1996 and 2001].","author":"Costes J. M.","year":"2003"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00189.x"},{"key":"e_1_2_8_21_2","first-page":"645","article-title":"Predictive factors for patient maintenance on buprenorphine high dosage treatment: a naturalistic study in primary care","volume":"25","author":"Gasquet I.","year":"1999","journal-title":"Encephale"},{"key":"e_1_2_8_22_2","first-page":"23","article-title":"Comparative value of buprenorphine and methadone","volume":"145","author":"Reisinger M.","year":"1994","journal-title":"Annales de Medecine Interne"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000052036"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000620"},{"key":"e_1_2_8_25_2","first-page":"945","article-title":"Differential cross\u2010tolerance to opioids in squirrel monkeys responding under a shock titration schedule","volume":"252","author":"Craft R. M.","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.1.39"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1191\/0960327102ht303oa"},{"key":"e_1_2_8_28_2","first-page":"974","article-title":"Fatal opioid toxicity\u2014a clinical perspective","volume":"94","author":"Henry J.","year":"1999","journal-title":"Addiction"},{"key":"e_1_2_8_29_2","first-page":"505","article-title":"Comparative analysis of buprenorphine\u2010 and norbuprenorphine\u2010induced analgesic effects based on pharmacokinetic\u2010pharmacodynamic modeling","volume":"272","author":"Ohtani M.","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-002-0292-0"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-002-0293-z"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2004.00790.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2004.00790.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:58:11Z","timestamp":1698753491000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2004.00790.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,16]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1360-0443.2004.00790.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00790.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,16]]},"assertion":[{"value":"2004-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}